Multiparticulate Systems of Ezetimibe Micellar System and Atorvastatin Solid Dispersion Efficacy of Low-Dose Ezetimibe/Atorvastatin on High-Fat Diet-Induced Hyperlipidemia and Hepatic Steatosis in Diabetic Rats
Open Access
- 20 March 2021
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (3) , 421
Abstract
The aim of this study was to develop multiparticulate systems with a combination of ezetimibe micellar systems and atorvastatin solid dispersions using croscarmellose as a hydrophilic vehicle and Kolliphor RH40 as a surfactant. The presence of a surfactant with low hydrophilic polymer ratios produces the rapid dissolution of ezetimibe through a drug–polymer interaction that reduces its crystallinity. The solid dispersion of atorvastatin with low proportions of croscarmellose showed drug–polymer interactions sufficient to produce the fast dissolution of atorvastatin. Efficacy studies were performed in diabetic Goto-Kakizaki rats with induced hyperlipidemia. The administration of multiparticulate systems of ezetimibe and atorvastatin at low (2 and 6.7 mg/kg) and high (3 and 10 mg/kg) doses showed similar improvements in levels of cholesterol, triglycerides, lipoproteins, alanine transaminase, and aspartate transaminase compared to the high-fat diet group. Multiparticulate systems at low doses (2 and 6.7 mg/kg of ezetimibe and atorvastatin) had a similar improvement in hepatic steatosis compared to the administration of ezetimibe and atorvastatin raw materials at high doses (3 and 10 mg/kg). These results confirm the effectiveness of solid dispersions with low doses of ezetimibe and atorvastatin to reduce high lipid levels and hepatic steatosis in diabetic rats fed a high-fat diet.Keywords
Funding Information
- Fundação para a Ciência e a Tecnologia (PTDC / BIM-MET / 4447/2014; POCI-01-0145-FEDER-016784)
- Ministerio de Ciencia e Innovación (MICINU, ref. RTI2018-093940-B-100)
- Universidad Complutense de Madrid (Research Group 910939)
This publication has 39 references indexed in Scilit:
- The effect of surfactants on the dissolution behavior of amorphous formulationsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2016
- Atorvastatin solid dispersion for bioavailability enhancementJournal of Advanced Pharmaceutical Technology & Research, 2016
- Evaluation of physicochemical properties and in vivo efficiency of atorvastatin calcium/ezetimibe solid dispersionsEuropean Journal of Pharmaceutical Sciences, 2016
- Design, optimization, and evaluation of ezetimibe solid supersaturatable self-nanoemulsifying drug delivery for enhanced solubility and dissolutionJournal of Pharmaceutical Investigation, 2015
- Preparation and pharmacodynamic assessment of ezetimibe nanocrystals: Effect of P-gp inhibitory stabilizer on particle size and oral absorptionColloids and Surfaces B: Biointerfaces, 2015
- Physicochemical characterization and pharmacological evaluation of ezetimibe-PVP K30 solid dispersions in hyperlipidemic ratsColloids and Surfaces B: Biointerfaces, 2015
- Effect of hydroxypropylcellulose and Tween 80 on physicochemical properties and bioavailability of ezetimibe-loaded solid dispersionCarbohydrate Polymers, 2015
- Effect of pharmaceutical excipients on the permeability of P-glycoprotein substrateJournal of Drug Delivery Science and Technology, 2014
- New formulation approaches to improve solubility and drug release from fixed dose combinations: Case examples pioglitazone/glimepiride and ezetimibe/simvastatinEuropean Journal of Pharmaceutics and Biopharmaceutics, 2013
- Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibeColloids and Surfaces B: Biointerfaces, 2010